Adverse events888

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 888

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Dose Escalation Part: Crizotinib 200mg+Axitinib 3mg	1	5
other	Anaemia	Blood and lymphatic system disorders	Dose Escalation Part: Crizotinib 250mg+Axitinib 3mg	0	3
other	Anaemia	Blood and lymphatic system disorders	Dose Escalation Part: Crizotinib 200 mg+Axitinib 5 mg	0	4
other	Anaemia	Blood and lymphatic system disorders	Dose Escalation Part: Crizotinib 250 mg+Axitinib 5 mg	0	10
other	Anaemia	Blood and lymphatic system disorders	Dose Expansion Part: Cohort 1 Crizotinib 250 mg+Axitinib 5 mg	0	21
other	Anaemia	Blood and lymphatic system disorders	Dose Expansion Part: Cohort 2 Crizotinib 250 mg+Axitinib 5 mg	2	7
other	Bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 200mg+Axitinib 3mg	0	5
other	Bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 250mg+Axitinib 3mg	0	3
other	Bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 200 mg+Axitinib 5 mg	0	4
other	Bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 250 mg+Axitinib 5 mg	1	10
other	Bradycardia	Cardiac disorders	Dose Expansion Part: Cohort 1 Crizotinib 250 mg+Axitinib 5 mg	0	21
other	Bradycardia	Cardiac disorders	Dose Expansion Part: Cohort 2 Crizotinib 250 mg+Axitinib 5 mg	0	7
other	Sinus bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 200mg+Axitinib 3mg	1	5
other	Sinus bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 250mg+Axitinib 3mg	0	3
other	Sinus bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 200 mg+Axitinib 5 mg	0	4
other	Sinus bradycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 250 mg+Axitinib 5 mg	0	10
other	Sinus bradycardia	Cardiac disorders	Dose Expansion Part: Cohort 1 Crizotinib 250 mg+Axitinib 5 mg	0	21
other	Sinus bradycardia	Cardiac disorders	Dose Expansion Part: Cohort 2 Crizotinib 250 mg+Axitinib 5 mg	0	7
other	Sinus tachycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 200mg+Axitinib 3mg	0	5
other	Sinus tachycardia	Cardiac disorders	Dose Escalation Part: Crizotinib 250mg+Axitinib 3mg	1	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01999972/events

API reference For AI assistants

Adverse events888

Sources 3

Read this list from software.